ACRS — Aclaris Therapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ACRS
| date | signal | measured base rate |
|---|---|---|
| 2026-08-04 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-07-07 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-26 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
| 2026-05-04 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-04-23 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-03-27 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-01 | Kolbeck Roland Wilhelm Chief Scientific Officer | Shares withheld for tax | 12.4K | 5.20 | 64.4K |
| 2026-08-01 | Kolbeck Roland Wilhelm Chief Scientific Officer | Option exercise | 36.4K | — | — |
| 2026-06-05 | Mehra Anand Director | Option exercise | 11.6K | — | — |
| 2026-06-05 | SCHIFF ANDREW N Director | Option exercise | 11.6K | — | — |
| 2026-06-05 | MILANO VINCENT Director | Option exercise | 11.6K | — | — |
| 2026-06-05 | Molineaux Christopher P. Director | Option exercise | 11.6K | — | — |
| 2026-06-05 | GOWEN MAXINE Director | Option exercise | 11.6K | — | — |
| 2026-06-05 | Humphries William D. Director | Option exercise | 11.6K | — | — |
| 2026-05-01 | Hall Jesse Wayne Chief Medical Officer | Shares withheld for tax | 9.3K | 4.41 | 41.1K |
| 2026-05-01 | Hall Jesse Wayne Chief Medical Officer | Option exercise | 36.4K | — | — |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BML Capital Management, LLC | 53.4M | 14.2M |
| Deep Track Capital, LP | 35.0M | 9.3M |
| BlackRock, Inc. | 27.8M | 7.4M |
| RA CAPITAL MANAGEMENT, L.P. | 25.5M | 6.8M |
| Vivo Capital, LLC | 25.0M | 6.7M |
| VANGUARD CAPITAL MANAGEMENT LLC | 19.4M | 5.2M |
| Frazier Life Sciences Management, L.P. | 18.5M | 4.9M |
| Rock Springs Capital Management LP | 16.8M | 4.5M |
| Decheng Capital LLC | 15.2M | 4.0M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 14.5M | 3.9M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about ACRS
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →